Topical administration of acyclovir
    1.
    发明授权
    Topical administration of acyclovir 失效
    阿昔洛韦的局部给药

    公开(公告)号:US08771712B2

    公开(公告)日:2014-07-08

    申请号:US12300090

    申请日:2007-05-02

    IPC分类号: A61K9/00 A61K31/522

    CPC分类号: A61K9/0014 A61K47/183

    摘要: The present invention provides a topical composition comprising (a) at least one delivery agent compound and (b) a acyclovir compound. Methods of treatment, and methods of preparing the topical composition are also provided.

    摘要翻译: 本发明提供一种局部组合物,其包含(a)至少一种递送剂化合物和(b)无环鸟苷化合物。 还提供了治疗方法和制备局部组合物的方法。

    Compositions For Buccal Delivery of Human Growth Hormone
    7.
    发明申请
    Compositions For Buccal Delivery of Human Growth Hormone 失效
    用于人类生长激素的颊传递的组合物

    公开(公告)号:US20080207513A1

    公开(公告)日:2008-08-28

    申请号:US11993941

    申请日:2006-07-05

    IPC分类号: A61K38/00 A61P43/00

    CPC分类号: A61K38/27 A61K9/006

    摘要: The present invention provides pharmaceutical compositions for buccal delivery of human growth hormone (hGH) comprising a delivery agent and hGH. The compositions of the present invention provide improved delivery of hGH compared to comparable oral compositions, resulting in increased serum concentrations of hGH. The present invention further provides for methods of stimulating tissue growth in an animal by buccally co-administering hGH and a delivery agent.

    摘要翻译: 本发明提供用于口服输送包含递送剂和hGH的人生长激素(hGH)的药物组合物。 与可比较的口服组合物相比,本发明的组合物提供了hGH的改善的递送,导致hGH的血清浓度增加。 本发明进一步提供通过颊内共施用hGH和递送剂刺激动物中的组织生长的方法。